We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
US-based Biogen has signed a share purchase agreement to sell its biologics manufacturing site in Hillerød, Denmark to Japanese tech company Fujifilm for a cash consideration of up to $890m.